Ribosomal protein S26 pseudogene 29 (RPS26P29)

Ribosomal protein S26 pseudogene 29 is a non-protein-coding genomic element classified as a pseudogene. It shares sequence similarity with the functional ribosomal protein S26 gene (RPS26), which is a component of the 40S ribosomal subunit involved in protein synthesis[4][9]. Unlike the parent gene, RPS26P29 does not encode a functional protein and is not considered a therapeutic target. Pseudogenes like RPS26P29 arise through duplication or retrotransposition events and may exist as processed or non-processed copies dispersed in the genome. There is no evidence or indication in current genetic databases (NCBI, UniProt, GeneCards) that RPS26P29 has a defined biological function, drug interactions, or direct disease relevance[9]. Its parent gene (RPS26) is associated with Diamond-Blackfan anemia, but this role does not extend to the pseudogene[1][3][4]. Pseudogenes are typically excluded from lists of actionable therapeutic targets because they do not produce functional protein products and are not targeted by drugs[9]. If your interest is in the ribosomal protein S26 (RPS26) itself, refer to the functional gene for relevant clinical, biological, and target data[1][4][5][8]. This entry is primarily recorded in gene annotation databases for completeness of genomic cataloging and is not suitable for drug development or direct biological interrogation.

Other names

40S ribosomal protein S26 pseudogene 29